GUNAR K ZAGARS to Humans
This is a "connection" page, showing publications GUNAR K ZAGARS has written about Humans.
Connection Strength
0.333
-
The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014 May 01; 120(9):1361-8.
Score: 0.009
-
Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Jul 01; 86(3):585-90.
Score: 0.009
-
Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment. Head Neck. 2010 Jun; 32(6):708-13.
Score: 0.007
-
Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol. 2009 Apr; 10(4):409-16.
Score: 0.006
-
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1376-82.
Score: 0.006
-
Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1124-9.
Score: 0.006
-
Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2006 Jan 01; 64(1):106-13.
Score: 0.005
-
Mortality after cure of testicular seminoma. J Clin Oncol. 2004 Feb 15; 22(4):640-7.
Score: 0.004
-
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):739-47.
Score: 0.004
-
Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):473-81.
Score: 0.004
-
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):482-8.
Score: 0.004
-
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003 May 15; 97(10):2530-43.
Score: 0.004
-
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003 May 15; 97(10):2544-53.
Score: 0.004
-
Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned. Int J Radiat Oncol Biol Phys. 2003 May 01; 56(1):21-7.
Score: 0.004
-
Radiation therapy for soft tissue sarcoma. Surg Oncol Clin N Am. 2003 Apr; 12(2):449-67, vii.
Score: 0.004
-
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):22-30; discussion 30-1.
Score: 0.004
-
Radiotherapy for stage II testicular seminoma. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):643-9.
Score: 0.004
-
Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):384-91.
Score: 0.004
-
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. 2001 Aug; 58(2):233-9.
Score: 0.004
-
Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1999 Jul 01; 44(4):809-19.
Score: 0.003
-
Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy. Urology. 1998 Oct; 52(4):647-52.
Score: 0.003
-
Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):517-23.
Score: 0.003
-
Regarding Zagars and Pollack. Int J Radiat Oncol Biol Phys. 1998 Jul 01; 41(4):973-4.
Score: 0.003
-
Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology. 1998 Jun; 51(6):991-7.
Score: 0.003
-
Malignant Peripheral Nerve Sheath Tumors: A Single Institution's Experience Using Combined Surgery and Radiation Therapy. Am J Clin Oncol. 2018 05; 41(5):465-470.
Score: 0.003
-
Androgen ablation in addition to radiation therapy for prostate cancer: is there true benefit? Semin Radiat Oncol. 1998 Apr; 8(2):95-106.
Score: 0.003
-
External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? Urology. 1998 Feb; 51(2):258-64.
Score: 0.003
-
Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Investig. 1998; 6(6):264-7.
Score: 0.003
-
Is there a role for radiation therapy for the management of phyllodes tumor of the breast? Radiat Oncol Investig. 1998; 6(6):289-90.
Score: 0.003
-
Soft Tissue Solitary Fibrous Tumor: Combined Surgery and Radiation Therapy Results in Excellent Local Control. Am J Clin Oncol. 2018 Jan; 41(1):81-85.
Score: 0.003
-
External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1011-8.
Score: 0.003
-
Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol. 1997 Sep; 44(3):213-21.
Score: 0.003
-
Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation. Cancer. 1997 Aug 15; 80(4):764-75.
Score: 0.003
-
Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997 Aug 01; 39(1):85-9.
Score: 0.003
-
Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy. Int J Radiat Oncol Biol Phys. 1997 May 01; 38(2):327-33.
Score: 0.003
-
Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer. 1997 Apr 01; 79(7):1370-80.
Score: 0.003
-
Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancer. Urology. 1997 Mar; 49(3):327-34.
Score: 0.003
-
Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996 Sep 01; 36(2):311-9.
Score: 0.003
-
Treatment-related fractures after combined modality therapy for soft tissue sarcomas of the proximal lower extremity: Can the risk be mitigated? Pract Radiat Oncol. 2016 May-Jun; 6(3):194-200.
Score: 0.003
-
Radiotherapy vs. surgery for prostate cancer: an age old question. Int J Radiat Oncol Biol Phys. 1996 May 01; 35(2):407-9.
Score: 0.003
-
Radiotherapy for stage T3b transitional cell carcinoma of the bladder. Semin Urol Oncol. 1996 May; 14(2):86-95.
Score: 0.003
-
Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):983-94.
Score: 0.003
-
Radiotherapy for regionally localized hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys. 1995 Nov 01; 33(4):907-12.
Score: 0.003
-
Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 1995 Aug 30; 33(1):23-35.
Score: 0.003
-
Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1995 May 15; 32(2):293-306.
Score: 0.002
-
Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):158-65.
Score: 0.002
-
The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M? Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):21-32.
Score: 0.002
-
Combined Limb-Sparing Surgery and Radiation Therapy to Treat Sarcomas of the Hands and Feet: Long-Term Cancer Outcomes and Morbidity. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1060-1068.
Score: 0.002
-
Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology. 1995 Mar; 45(3):476-83.
Score: 0.002
-
Gleason grade and other prognostic factors--response to Drs. Hammond and Grignon. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):435.
Score: 0.002
-
The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):237-45.
Score: 0.002
-
Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation. Int J Radiat Oncol Biol Phys. 1995 Jan 01; 31(1):13-9.
Score: 0.002
-
Soft tissue sarcomas of the extremities: continuing challenges for a multidisciplinary team. Cancer Invest. 1995; 13(1):137-8.
Score: 0.002
-
Neutron therapy in prostate cancer--is the therapeutic ratio improved? Int J Radiat Oncol Biol Phys. 1995 Jan 01; 31(1):204-5.
Score: 0.002
-
Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. J Urol. 1994 Nov; 152(5 Pt 2):1786-91.
Score: 0.002
-
Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol. 1994 Oct; 33(1):23-30.
Score: 0.002
-
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome. J Urol. 1994 May; 151(5):1330-3.
Score: 0.002
-
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy. Cancer. 1994 Apr 01; 73(7):1904-12.
Score: 0.002
-
The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Mar 01; 28(4):821-8.
Score: 0.002
-
The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatment. Radiother Oncol. 1994 Feb; 30(2):121-7.
Score: 0.002
-
Serum PSA as a tumor marker for patients undergoing definitive radiation therapy. Urol Clin North Am. 1993 Nov; 20(4):737-47.
Score: 0.002
-
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer. 1993 Sep 01; 72(5):1709-25.
Score: 0.002
-
The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1993 Sep 01; 27(1):39-45.
Score: 0.002
-
The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer. Cancer. 1993 Aug 01; 72(3):832-42.
Score: 0.002
-
Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. Cancer. 1993 Jul 15; 72(2):538-48.
Score: 0.002
-
Post-orchiectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys. 1993 Jun 15; 26(3):381-90.
Score: 0.002
-
Radiotherapy versus surgery for stage C prostate cancer. Urology. 1993 Jun; 41(6):605.
Score: 0.002
-
In regard to Pollack et al., prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. IJROBP 2002;53:1097-1105. Int J Radiat Oncol Biol Phys. 2003 Apr 01; 55(5):1461; author reply 1461-2.
Score: 0.002
-
A commentary on dose escalation and bNED in prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):1151; author reply 1151-2.
Score: 0.002
-
Stage I testicular seminoma following orchidectomy--to treat or not to treat. Eur J Cancer. 1993; 29A(14):1923-4.
Score: 0.002
-
A population-based study of the quality of care in the diagnosis of large (=5 cm) soft tissue sarcomas. Am J Clin Oncol. 2012 Oct; 35(5):455-61.
Score: 0.002
-
Treatment of seminoma arising in cryptorchid testes. Int J Radiat Oncol Biol Phys. 1992; 24(1):153-9.
Score: 0.002
-
Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1992; 23(1):47-53.
Score: 0.002
-
The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer. 1991 Dec 01; 68(11):2370-7.
Score: 0.002
-
Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Cancer. 2011 Oct 15; 117(20):4747-55.
Score: 0.002
-
Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer. 1991 Jan 15; 67(2):412-20.
Score: 0.002
-
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck. 2011 May; 33(5):661-7.
Score: 0.002
-
Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol. 1990 Jan; 143(1):37-40.
Score: 0.002
-
Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009 Jul 15; 115(14):3262-70.
Score: 0.002
-
The influence of pelvic node irradiation on prognosis. Int J Radiat Oncol Biol Phys. 1989 Mar; 16(3):882.
Score: 0.002
-
Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy. Cancer. 2008 Jul 15; 113(2):411-8.
Score: 0.002
-
Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study. Int J Radiat Oncol Biol Phys. 1988 Jun; 14(6):1085-91.
Score: 0.002
-
Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys. 1988 Apr; 14(4):693-9.
Score: 0.002
-
The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1988 Apr; 14(4):701-9.
Score: 0.002
-
Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):441-7.
Score: 0.001
-
Seminoma with bulky abdominal disease. Int J Radiat Oncol Biol Phys. 1988 Feb; 14(2):395-7.
Score: 0.001
-
Testicular seminoma: the M. D. Anderson experience. An analysis of pathological and patient characteristics, and treatment recommendations. J Urol. 1988 Feb; 139(2):311-4.
Score: 0.001
-
Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation. Cancer. 1987 Oct 01; 60(7):1489-99.
Score: 0.001
-
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007 Oct; 246(4):675-81; discussion 681-2.
Score: 0.001
-
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 01; 70(3):760-5.
Score: 0.001
-
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1173-80.
Score: 0.001
-
Optimizing treatment of desmoid tumors. J Clin Oncol. 2007 May 01; 25(13):1785-91.
Score: 0.001
-
Inter-tumor heterogeneity and radiation dose-control curves. Radiother Oncol. 1987 Apr; 8(4):353-61.
Score: 0.001
-
Stage I testicular seminoma: rationale for postorchiectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1987 Feb; 13(2):155-62.
Score: 0.001
-
The role of radiation in stage II testicular seminoma. Int J Radiat Oncol Biol Phys. 1987 Feb; 13(2):163-70.
Score: 0.001
-
Periosteal margin in soft-tissue sarcoma. Cancer. 2007 Feb 01; 109(3):598-602.
Score: 0.001
-
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer. 2006 Nov 15; 107(10):2455-61.
Score: 0.001
-
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63.
Score: 0.001
-
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006 Sep; 13(9):1209-15.
Score: 0.001
-
Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy. Cancer. 1985 Oct 15; 56(8):1905-12.
Score: 0.001
-
Laparotomy-staged IA versus IIA Hodgkin's disease. A comparative study with evaluation of prognostic factors for stage IIA disease. Cancer. 1985 Aug 15; 56(4):864-73.
Score: 0.001
-
Misonidazole and hemibody irradiation in the palliation of widespread metastases. Final report of an RTOG study. Am J Clin Oncol. 1985 Aug; 8(4):293-7.
Score: 0.001
-
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol. 2004 Dec; 11(12):1079-84.
Score: 0.001
-
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80.
Score: 0.001
-
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.
Score: 0.001
-
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology. 2003 Oct; 62(4):707-13.
Score: 0.001
-
Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):158-65.
Score: 0.001
-
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7.
Score: 0.001
-
The follow-up of adult soft-tissue sarcomas. Semin Oncol. 2003 Jun; 30(3):413-6.
Score: 0.001
-
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x. Cancer. 2003 Apr 01; 97(7):1630-8.
Score: 0.001
-
Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer. 2003 Apr 01; 97(7):1789-96.
Score: 0.001
-
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol. 2002 Dec 01; 20(23):4555-8.
Score: 0.001
-
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 2002 Nov 01; 54(3):677-85.
Score: 0.001
-
Surgical management of soft tissue sarcomas of the hand and foot. Cancer. 2002 Aug 15; 95(4):852-61.
Score: 0.001
-
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1097-105.
Score: 0.001
-
Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002 Jul 15; 95(2):377-88.
Score: 0.001
-
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy. Clin Cancer Res. 2002 May; 8(5):1148-54.
Score: 0.001
-
Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):964-72.
Score: 0.001
-
Initial pharmacology and toxicology of intravenous desmethylmisonidazole. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr; 8(3-4):371-5.
Score: 0.001
-
Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002 Jan 15; 20(2):521-7.
Score: 0.001
-
Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct; 166(4):1306-10.
Score: 0.001
-
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5.
Score: 0.001
-
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 2000 Dec 01; 18(23):3904-11.
Score: 0.001
-
Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000 Oct 01; 89(7):1502-11.
Score: 0.001
-
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000 Oct 01; 48(3):635-42.
Score: 0.001
-
Minisatellite mutation frequency in human sperm following radiotherapy. Mutat Res. 2000 Sep 20; 453(1):67-75.
Score: 0.001
-
Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy. Prostate. 1999 Nov 01; 41(3):166-72.
Score: 0.001
-
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80.
Score: 0.001
-
Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome. Cancer. 1999 Apr 01; 85(7):1577-85.
Score: 0.001
-
Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity. Semin Oncol. 1999 Apr; 26(2):150-61.
Score: 0.001
-
Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys. 1999 Jan 15; 43(2):379-83.
Score: 0.001
-
Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999 Jan; 17(1):158-67.
Score: 0.001
-
Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1007-14.
Score: 0.001
-
Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):563-72.
Score: 0.001
-
Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 1998 Oct 01; 42(3):661-72.
Score: 0.001
-
The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys. 1998 Mar 01; 40(4):823-7.
Score: 0.001
-
Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1997 Oct 01; 39(3):687-95.
Score: 0.001
-
Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res. 1997 Oct; 3(10):1823-9.
Score: 0.001
-
The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation. Prostate. 1997 Apr 01; 31(1):21-8.
Score: 0.001
-
Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1997 Jan 01; 37(1):41-9.
Score: 0.001
-
Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):891-905.
Score: 0.001
-
Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1996 May 01; 35(2):281-7.
Score: 0.001
-
Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy. Cancer. 1996 Apr 15; 77(8):1515-23.
Score: 0.001
-
Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology. 1996 Mar; 47(3):305-10.
Score: 0.001
-
Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys. 1996 Feb 01; 34(3):555-64.
Score: 0.001
-
The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol. 1995 Dec; 154(6):2059-63; discussion 2063-4.
Score: 0.001
-
Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys. 1995 May 15; 32(2):331-40.
Score: 0.001
-
Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):13-20.
Score: 0.001
-
Frequency and characterization of p53 mutations in clinically localized prostate cancer. Urology. 1995 Mar; 45(3):470-5.
Score: 0.001
-
Local treatment for prostate cancer: 90 years later--response to M. V. Pilepich. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):436.
Score: 0.001
-
Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology. 1994 Dec; 44(6):869-75.
Score: 0.001
-
Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer. 1994 Nov 15; 74(10):2819-27.
Score: 0.001
-
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. Urology. 1994 Nov; 44(5):711-8.
Score: 0.001
-
Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. J Urol. 1994 Nov; 152(5 Pt 2):1799-805.
Score: 0.001
-
Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):279-87.
Score: 0.001
-
Influence of initial presentation on treatment outcome of clinically localized prostate cancer treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):331-7.
Score: 0.001
-
Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):267-77.
Score: 0.001
-
Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer. Urology. 1994 Aug; 44(2):215-20.
Score: 0.001
-
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer. 1994 Jul 15; 74(2):670-8.
Score: 0.001
-
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation. Am J Hematol. 1994 Jun; 46(2):82-6.
Score: 0.001
-
Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Cancer. 1994 Apr 01; 73(7):1895-903.
Score: 0.001
-
Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression. Cancer. 1993 Jun 01; 71(11):3783-7.
Score: 0.001
-
Primary carcinoma of the female urethra. Results of radiation therapy. Cancer. 1993 May 15; 71(10):3102-8.
Score: 0.001
-
Complications following external beam radiation therapy for prostate cancer: an analysis of patients treated with and without staging pelvic lymphadenectomy. J Urol. 1991 Sep; 146(3):798-802.
Score: 0.000
-
Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle, and foot. Cancer. 1990 Dec 15; 66(12):2482-91.
Score: 0.000
-
The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1383-8.
Score: 0.000
-
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood. 1990 Nov 01; 76(9):1860-6.
Score: 0.000
-
Radiation therapy of stage C prostate cancer: significance of Gleason grade to survival. Semin Urol. 1990 Nov; 8(4):225-31.
Score: 0.000
-
Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys. 1990 Jul; 19(1):37-40.
Score: 0.000
-
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease. Bone Marrow Transplant. 1990 Apr; 5(4):269-72.
Score: 0.000
-
Spinal cord dose reduction using an anterior 13 MeV electron field situated between a split anterior 60Co supraclavicular field. Int J Radiat Oncol Biol Phys. 1987 Oct; 13(10):1571-5.
Score: 0.000
-
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood. 1987 Sep; 70(3):869-72.
Score: 0.000
-
Protection by WR-2721 of human bone marrow function following irradiation. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1505-8.
Score: 0.000
-
Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia. J Clin Oncol. 1986 Jun; 4(6):906-11.
Score: 0.000
-
High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies. Eur J Cancer Clin Oncol. 1986 Jun; 22(6):677-84.
Score: 0.000
-
Hodgkin's disease: is there a price for successful treatment? A 25-year experience. Int J Radiat Oncol Biol Phys. 1986 Feb; 12(2):153-66.
Score: 0.000
-
Systemic hemibody irradiation for overt and occult metastases. Cancer. 1985 May 01; 55(9 Suppl):2210-21.
Score: 0.000
-
Single-dose half-body irradiation for the palliation of multiple bone metastases from solid tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1981 Jun; 7(6):773-81.
Score: 0.000